You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ABL001,

Showing 26 - 50 of 107
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

Completed
  • Chronic Myeloid Leukemia
    • East Hanover, New Jersey
      Novartis
    Nov 20, 2023

    Leukemia,Myeloid, Chronic Trial in France (Blood and bone marrow sample)

    Not yet recruiting
    • Leukemia,Myeloid, Chronic
    • Blood and bone marrow sample
    • Annecy, France
    • +15 more
    Nov 10, 2023

    Acute Lymphoid Leukemia, Acute Lymphoblastic Leukemia Trial in Aurora (CD19 Directed CAR T Cell)

    Not yet recruiting
    • Acute Lymphoid Leukemia
    • Acute Lymphoblastic Leukemia
    • CD19 Directed CAR T Cell
    • Aurora, Colorado
      University of Colorado Hospital
    Sep 12, 2022

    Chronic Myeloid Leukemia Trial in Worldwide

    Recruiting
    • Chronic Myeloid Leukemia
      • Montréal, Quebec, Canada
      • +25 more
      Jul 25, 2022

      Concomitant Medications at CML Diagnosis

      Completed
      • Chronic Myeloid Leukemia
      • the prevalence of comorbid conditions
      • (no location specified)
      Sep 16, 2023

      Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs

      Not yet recruiting
      • Myeloproliferative Neoplasms (MPNs)
      • Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
      • (no location specified)
      Mar 24, 2023

      Needs of 3L+ CP-CML and With T315I-mutated CML Patients

      Completed
      • Chronic Myeloid Leukemia
      • 3L Therapy
      • T315I
      • Lyon, France
        Novartis Investigative Site
      Nov 9, 2022

      Solid Tumors Trial run by the National Cancer Institute (NCI) (Nilotinib + Paclitaxel)

      Recruiting
      • Solid Tumors
      • Nilotinib + Paclitaxel
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 24, 2022

      3L+ Therapies Among Chronic Myeloid Leukemia and Those With

      Completed
      • Chronic Myeloid Leukemia
        • East Hanover, New Jersey
          Novartis Investigative Site
        Nov 11, 2022

        Pre-existing Kinase Domain Mutations in Ph-positive Leukemias

        Recruiting
        • Leukemia
          • Vienna, Austria
            Medical Universitiy of Vienna
          Mar 23, 2021

          Acute Lymphoblastic Leukemia, Pediatric Trial in Canada, United States (Pegaspargase, Erwinia asparaginase, Cyclophosphamide)

          Active, not recruiting
          • Acute Lymphoblastic Leukemia, Pediatric
          • Boston, Massachusetts
          • +8 more
          Nov 10, 2022

          Outcomes of Tyrosine Kinase Inhibitor(TKI)Stopping in Chronic

          Recruiting
          • Folate
          • +2 more
            • Nantong, China
              Affliated Hospital of Nantong University
            Dec 13, 2021

            Generic Imatinib Compared to Glivec® in Real-Life Management of

            Not yet recruiting
            • Chronic Myeloid Leukemia
            • Cairo, Egypt
            • +1 more
            Mar 16, 2022

            Chronic Myeloid Leukemia (CML), Pancreatic Ca, Colon/Rectal Ca Trial run by the National Heart, Lung, and Blood Institute

            Completed
            • Chronic Myeloid Leukemia (CML)
            • +4 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Dec 31, 2022

            Hematologic Diseases, Hematologic Malignancy, Acute Lymphoblastic Leukemia Trial in Miami (device, procedure, drug)

            Withdrawn
            • Hematologic Diseases
            • +5 more
            • CliniMACS
            • +7 more
            • Miami, Florida
              Miami Cancer Institute at Baptist Health, Inc.
            Sep 26, 2022

            Study Conducted Among Patients With CML

            Completed
            • Chronic Myeloid Leukemia
            • Tyrosine Kinase Inhibitors (TKIs)
            • East Hanover, New Jersey
              Novartis Investigative Site
            Jul 25, 2022

            Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

            Completed
            • Adult Acute Megakaryoblastic Leukemia (M7)
            • +13 more
            • Philadelphia, Pennsylvania
              Thomas Jefferson University
            Feb 2, 2023

            Misoprostol Allergy Trial in Cairo (Misoprostol 200mcg Tab, Misoprostol Pill)

            Recruiting
            • Misoprostol Allergy
            • Misoprostol 200mcg Tab
            • Misoprostol Pill
            • Cairo, Egypt
              faculty of medicine, Kasr el ainy hospital, Cairo university
            Jun 24, 2023

            TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy

            Recruiting
            • Chronic Myeloid Leukemia
            • Pisa, Italy
            • +1 more
            Jan 4, 2022

            Chronic Myeloid Leukemia Trial in Worldwide (Stopping treatment with TKI)

            Completed
            • Chronic Myeloid Leukemia
            • Stopping treatment with TKI
            • Brno, Czechia
            • +49 more
            Oct 29, 2021

            Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Trial in Worldwide (Nilotinib)

            Completed
            Has Results
            • Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
            • Linz, Oberoesterreich, Austria
            • +207 more
            Jun 23, 2021

            Chronic Myeloid Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Atlanta (G-CSF mobilized CD34+ selected

            No longer available
            • Chronic Myeloid Leukemia
            • +2 more
            • G-CSF mobilized CD34+ selected cells for transplantation
            • Atlanta, Georgia
              Emory University/Winship Cancer Institute
            Feb 28, 2022

            Leukemia, Myeloid, Chronic-Phase Trial in Bordeaux (Imatinib Mesylate 600 MG Oral Tablet, Imatinib Mesylate 400 MG Oral Tablet,

            Terminated
            Has Results
            • Leukemia, Myeloid, Chronic-Phase
            • Imatinib Mesylate 600 MG Oral Tablet
            • +2 more
            • Bordeaux, Aquitaine, France
              Institut Bergonié
            Dec 30, 2020

            Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL), Ph+ Mixed Phenotype Acute Leukemia (MPAL),

            Recruiting
            • Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL)
            • +2 more
            • Phoenix, Arizona
            • +69 more
            Aug 23, 2022

            Hematologic Malignancy, Acute Myeloid Leukemia, MDS Trial in Chengdu, Shenzhen (CLL1-CD33 cCAR T cells)

            Recruiting
            • Hematologic Malignancy
            • +4 more
            • CLL1-CD33 cCAR T cells
            • Chengdu, China
            • +1 more
            May 17, 2021